- Business Wire•14 days ago
MetaStat, Inc. , a pre-commercial biotechnology company, today announced that Douglas A. Hamilton, President and Chief Executive Officer, is scheduled to present at the 19th Annual BIO CEO & Investor Conference in New York City.
- Business Wire•last month
MetaStat, Inc. , a pre-commercial biotechnology company focused on the development and commercialization of diagnostic tests that are prognostic for risk of cancer metastasis, companion diagnostics to predict drug response, and anti-metastatic drugs, announced today that the Company will be presenting at the 9th Annual Biotech Showcase™ conference held in San Francisco from January 9th -11th at the ...
- Business Wire•2 months ago
MetaStat, Inc. , a pre-commercial biotechnology company, today announced it has received California, Florida, Pennsylvania, and Rhode Island state licensure for its next-generation digital pathology laboratory in Boston, Massachusetts.
MTST : Summary for METASTAT INC - Yahoo Finance
MetaStat, Inc. (MTST)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
|Day's Range||1.45 - 1.60|
|52 Week Range||1.15 - 3.45|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-0.41|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|